Bay Colony Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.1M Buy
5,083
+83
+2% +$84.8K 0.68% 33
2026
Q1
$4.6M Sell
5,000
-548
-10% -$556K 0.56% 37
2025
Q4
$5.96M Sell
5,548
-322
-5% -$308K 0.71% 26
2025
Q3
$4.48M Buy
5,870
+425
+8% +$316K 0.53% 35
2025
Q2
$4.24M Buy
5,445
+372
+7% +$289K 0.59% 32
2025
Q1
$4.17M Sell
5,073
-38
-0.7% -$31.6K 0.64% 26
2024
Q4
$3.95M Buy
5,111
+745
+17% +$617K 0.58% 30
2024
Q3
$3.87M Sell
4,366
-1,061
-20% -$954K 0.59% 34
2024
Q2
$4.91M Sell
5,427
-532
-9% -$426K 0.82% 23
2024
Q1
$4.64M Sell
5,959
-1,327
-18% -$944K 0.82% 23
2023
Q4
$4.25M Buy
7,286
+1,872
+35% +$1.09M 0.83% 22
2023
Q3
$2.91M Sell
5,414
-343
-6% -$177K 0.7% 27
2023
Q2
$2.7M Sell
5,757
-140
-2% -$58.7K 0.65% 34
2023
Q1
$2.01M Sell
5,897
-103
-2% -$34.7K 0.53% 44
2022
Q4
$2.19M Sell
6,000
-356
-6% -$126K 0.58% 36
2022
Q3
$2.06M Buy
6,356
+211
+3% +$66.9K 0.61% 32
2022
Q2
$2.03M Sell
6,145
-323
-5% -$97K 0.52% 41
2022
Q1
$1.85M Buy
6,468
+430
+7% +$111K 0.44% 56
2021
Q4
$1.67M Buy
6,038
+597
+11% +$151K 0.48% 59
2021
Q3
$1.26M Sell
5,441
-147
-3% -$36.3K 0.41% 73
2021
Q2
$1.28M Buy
5,588
+1,311
+31% +$263K 0.43% 70
2021
Q1
$799K Buy
4,277
+129
+3% +$25.2K 0.31% 101
2020
Q4
$700K Buy
4,148
+614
+17% +$91.7K 0.37% 83
2020
Q3
$523K Buy
3,534
+910
+35% +$141K 0.32% 94
2020
Q2
$431K Buy
2,624
+7
+0.3% +$1.07K 0.31% 96
2020
Q1
$363K Buy
2,617
+848
+48% +$117K 0.33% 99
2019
Q4
$250K Buy
+1,769
New +$205K 0.16% 209
2018
Q3
Sell
-1,336
Closed -$114K 603
2018
Q2
$114K Buy
+1,336
New +$110K 0.08% 228

Other funds holding LLY

Bay Colony Advisors's LLY Position: Q2 2026 in Review

Bay Colony Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $84.8K and bringing the position to 5,083 shares worth $6.1M. The position accounts for 0.68% of the portfolio, ranked #33.

Bay Colony Advisors first reported a position in LLY in Q2 2018 and has held it in 28 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bay Colony Advisors held 5,083 shares of Eli Lilly worth $6.1M as of Q2 2026.
  • Bay Colony Advisors bought 83 Eli Lilly shares in Q2 2026, an estimated $84.8K.
  • Eli Lilly made up 0.68% of Bay Colony Advisors's portfolio in Q2 2026, its #33 holding.
  • Bay Colony Advisors first reported a position in Eli Lilly in Q2 2018 and has held it in 28 quarters since.
  • 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.